AngioDynamics Inc (STU:UG2)
€ 5.9 0.05 (0.85%) Market Cap: 229.90 Mil Enterprise Value: 181.36 Mil PE Ratio: 0 PB Ratio: 1.16 GF Score: 57/100

AngioDynamics Inc at UBS Global Healthcare Conference (Virtual) Transcript

May 18, 2020 / 01:10PM GMT
Release Date Price: €9.5 (+3.83%)
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Thanks. Good morning. Thanks for joining us. I'm Matt Taylor, UBS's U.S. medical supplies and devices analyst, and we're really pleased to be joined by management from AngioDynamics. We have on the line with us Jim Clemmer, who's the President and CEO of the company.

And AngioDynamics is a diversified med tech company that has businesses that cross a number of different areas involved with both critical care and elective care that we'll get into later in the program here, including devices for vascular access, oncology treatment, vascular interventions. And they've been very active in business development to move into some areas that are higher growth and higher margin over the last couple of years.

So Jim, thanks a lot for joining us today, and I'm excited to dive into some topics on Angio with you.

James C. Clemmer
AngioDynamics, Inc. - CEO, President & Director

So thanks, Matt, for the invitation to the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot